CME (CME) 10-Q2 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2022	Oct. 12, 2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-31553
Entity Registrant Name	CME GROUP INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-4459170
Entity Address, Street Address	20 South Wacker Drive
Entity Address, City	Chicago
Entity Address, State	IL
Entity Address, Postal Zip Code	60606
City Area Code	312
Local Phone Number	930-1000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of each class	Class A Common Stock
Trading symbol	CME
Name of each exchange on which registered	NASDAQ
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001156375
Amendment Flag	false
Class A Common Stock [Member]
Entity Common Stock, Shares Outstanding		359,724,979
Class B Common Stock, Class B-1 [Member]
Entity Common Stock, Shares Outstanding		625
Class B Common Stock, Class B-2 [Member]
Entity Common Stock, Shares Outstanding		813
Class B Common Stock, Class B-3 [Member]
Entity Common Stock, Shares Outstanding		1,287
Class B Common Stock, Class B-4 [Member]
Entity Common Stock, Shares Outstanding		413

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents		$ 2,130.1	$ 2,834.9
Marketable securities		91.3	115
Accounts receivable, net of allowance of $7.3 and $5.6		580.2	434.5
Other current assets (includes $4.6 and $4.8 in restricted cash)		476.4	427.8
Performance bonds and guaranty fund contributions		139,974.9	157,949.6
Total current assets		143,252.9	161,761.8
Property, net of accumulated depreciation and amortization of $1,111.0 and $1,039.4		465.5	505.3
Intangible assets—trading products	[1]	17,175.3	17,175.3
Intangible assets—other, net		3,302.2	3,532
Goodwill		10,447.3	10,528
Other assets (includes $0.2 and $0.5 in restricted cash)		3,788.3	3,277.9
Total Assets		178,431.5	196,780.3
Liabilities and Equity
Accounts payable		95	48.8
Short-term Debt		14.5	749.4
Other current liabilities		488.3	1,650.6
Performance bonds and guaranty fund contributions		139,974.9	157,949.6
Total current liabilities		140,572.7	160,398.4
Long-term debt		3,421.8	2,695.7
Deferred income tax liabilities, net		5,351.5	5,390.4
Other liabilities		834.7	896.5
Total Liabilities		150,180.7	169,381
Shareholders' Equity:
Preferred stock, $0.01 par value, 10,000 shares authorized as of September 30, 2022 and December 31, 2021; 4,584 issued and outstanding as of September 30, 2022 and December 31, 2021		0	0
Additional paid-in capital		22,235.3	22,190.3
Retained earnings		6,111.7	5,151.9
Accumulated other comprehensive income (loss)		(99.8)	53.5
Total CME Group Shareholders’ Equity		28,250.8	27,399.3
Total Liabilities and Equity		178,431.5	196,780.3
Class A Common Stock [Member]
Shareholders' Equity:
Common stock		3.6	3.6
Class B Common Stock [Member]
Shareholders' Equity:
Common stock		$ 0	$ 0

[1]Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits. (2) The activity from deconsolidation includes intangible assets as part of the contribution of the net assets of the optimization business to OSTTRA.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Accounts receivable, allowance	$ 7.3	$ 5.6
Short-term restricted cash	4.6	4.8
Accumulated depreciation and amortization, property	1,111	1,039.4
Long-term restricted cash	$ 0.2	$ 0.5
Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	4,584,000	4,584,000
Preferred stock, shares outstanding (in shares)	4,584,000	4,584,000
Class A Common Stock [Member]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	358,877,000	358,599,000
Common stock, shares outstanding (in shares)	358,877,000	358,599,000
Class B Common Stock [Member]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	3,000	3,000
Common stock, shares issued (in shares)	3,000	3,000
Common stock, shares outstanding (in shares)	3,000	3,000

Consolidated Statements Of Inco

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Total Revenues	$ 1,227.8	$ 1,109.9	$ 3,811.6	$ 3,542.4
Expenses
Compensation and benefits	189.6	198.6	560.1	635.3
Technology	46.8	49.3	138.6	146.8
Professional fees and outside services	35.1	45.2	98.9	119.4
Amortization of purchased intangibles	55.5	59	171	179
Depreciation and amortization	34.5	37.2	101	111.9
Licensing and other fee agreements	83.6	57.6	247.6	176.5
Other	43.9	49.3	146.8	160
Total Expenses	489	496.2	1,464	1,528.9
Operating Income	738.8	613.7	2,347.6	2,013.5
Non-Operating Income (Expense)
Investment income	686.2	145.8	1,046.2	239.1
Interest and other borrowing costs	(40.4)	(41.8)	(122.8)	(125)
Equity in net earnings of unconsolidated subsidiaries	76.5	66.4	237.1	178.3
Other non-operating income (expense)	(581.1)	311.8	(845.1)	268.4
Total Non-Operating Income (Expense)	141.2	482.2	315.4	560.8
Income before Income Taxes	880	1,095.9	2,663	2,574.3
Income tax provision	200.4	169.6	609.9	562.6
Net Income	679.6	926.3	2,053.1	2,011.7
Less: net (income) loss attributable to non-controlling interests	0	0.2	0	(0.5)
Net Income Attributable to CME Group	679.6	926.5	2,053.1	2,011.2
Net Income Attributable to Common Shareholders of CME Group	$ 671.1	$ 926.5	$ 2,027.2	$ 2,011.2
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic (in dollars per share)	$ 1.87	$ 2.59	$ 5.65	$ 5.61
Diluted (in dollars per share)	$ 1.87	$ 2.58	$ 5.64	$ 5.60
Weighted Average Number of Common Shares:
Basic (in shares)	358,715	358,363	358,655	358,258
Diluted (in shares)	359,288	358,988	359,206	358,894
Clearing and transaction fees [Member]
Revenues
Total Revenues	$ 998.6	$ 878.9	$ 3,161.3	$ 2,815.8
Market data and information services
Revenues
Total Revenues	154.3	145.4	457.7	434.8
Other
Revenues
Total Revenues	$ 74.9	$ 85.6	$ 192.6	$ 291.8

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net Income	$ 679.6	$ 926.3	$ 2,053.1	$ 2,011.7
Other comprehensive income (loss), net of tax:
Net unrealized holding gains (losses) arising during the period	(0.7)	(0.2)	(3)	(0.9)
Reclassification of net (gains) losses on sales included in investment income	0	(0.2)	0	(0.2)
Income tax benefit (expense)	0.1	0	0.7	0.2
Investment securities, net	(0.6)	0	(2.3)	(0.5)
Net change in defined benefit plans arising during the period	0	0	(3.7)	0
Amortization of net actuarial (gains) losses included in compensation and benefits expense	0.3	1.1	0.9	3.3
Income tax benefit (expense)	(0.1)	(0.2)	0.7	(0.8)
Defined benefit plans, net	0.2	0.9	(2.1)	2.5
Reclassification of net unrealized (gains) losses to interest expense and other non-operating income (expense)	(0.9)	(0.3)	(1)	(0.9)
Income tax benefit (expense)	0.2	0	0.2	0.2
Derivative investments, net	(0.7)	(0.3)	(0.8)	(0.7)
Foreign currency translation adjustments	(67)	(29)	(148.1)	(58.6)
Reclassification of net currency (gains) losses from foreign entities to other non-operating (income) and expense	0	(40.3)	0	(40.3)
Foreign currency translation, net	(67)	(69.3)	(148.1)	(98.9)
Other comprehensive income (loss), net of tax	(68.1)	(68.7)	(153.3)	(97.6)
Comprehensive income	611.5	857.6	1,899.8	1,914.1
Less: comprehensive (income) loss attributable to non-controlling interests	0	0.2	0	(0.5)
Comprehensive income attributable to CME Group	$ 611.5	$ 857.8	$ 1,899.8	$ 1,913.6

Consolidated Statements Of Shar

Consolidated Statements Of Shareholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock And Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Parent [Member]	Noncontrolling Interest [Member]	Class A Common Stock [Member]	Class A Common Stock [Member] Common Stock And Additional Paid-In Capital [Member]	Class B Common Stock [Member]	Class B Common Stock [Member] Common Stock And Additional Paid-In Capital [Member]	Preferred Stock [Member] Common Stock And Additional Paid-In Capital [Member]
Balance (in shares) at Dec. 31, 2020								358,110		3
Balance at Dec. 31, 2020	$ 26,351.5	$ 21,189.1	$ 4,995.9	$ 134.9	$ 26,319.9
Balance at Dec. 31, 2020						$ 31.6
Less: net (income) loss attributable to non-controlling interests	(0.5)					(0.5)
Net Income Attributable to CME Group	2,011.2		2,011.2		2,011.2
Net Income	2,011.7
Other comprehensive income (loss), net of tax	(97.6)			(97.6)	(97.6)
Dividends, Cash	(969.7)		(969.7)		(969.7)
Purchase of noncontrolling interest	(52)	(19.9)			(19.9)	32.1
Exercise of stock options, shares								102
Exercise of stock options	5.5	5.5			5.5
Vesting of issued restricted Class A common stock, shares								329
Vesting of issued restricted Class A common stock	(31.2)	(31.2)			(31.2)
Stock Issued During Period, Shares, Issued for Services								13
Stock Issued During Period, Value, Issued for Services	2.9	2.9			2.9
Stock Issued During Period, Shares, Employee Stock Purchase Plans								20
Stock Issued During Period, Value, Employee Stock Purchase Plan	4.4	4.4			4.4
Stock-based compensation	56.6	56.6			56.6
Balance (in shares) at Sep. 30, 2021								358,574		3
Balance at Sep. 30, 2021	27,282.1	21,207.4	6,037.4	37.3	27,282.1
Balance at Sep. 30, 2021						0
Balance (in shares) at Jun. 30, 2021								358,305		3
Balance at Jun. 30, 2021	26,787.4	21,222.7	5,434.5	106	26,763.2
Balance at Jun. 30, 2021						24.2
Less: net (income) loss attributable to non-controlling interests	0.2					0.2
Net Income Attributable to CME Group	926.5		926.5		926.5
Net Income	926.3
Other comprehensive income (loss), net of tax	(68.7)			(68.7)	(68.7)
Dividends, Cash	(323.6)		(323.6)		(323.6)
Purchase of noncontrolling interest	(39.5)	(15.5)			(15.5)	24
Exercise of stock options, shares								43
Exercise of stock options	2.3	2.3			2.3
Vesting of issued restricted Class A common stock, shares								226
Vesting of issued restricted Class A common stock	(17.7)	(17.7)			(17.7)
Stock-based compensation	15.6	15.6			15.6
Balance (in shares) at Sep. 30, 2021								358,574		3
Balance at Sep. 30, 2021	27,282.1	21,207.4	6,037.4	37.3	27,282.1
Balance at Sep. 30, 2021						$ 0
Balance (in shares) at Dec. 31, 2021							358,599	358,599	3	3	4,584
Balance at Dec. 31, 2021	27,399.3	22,193.9	5,151.9	53.5	27,399.3
Less: net (income) loss attributable to non-controlling interests	0
Net Income Attributable to CME Group	2,053.1		2,053.1		2,053.1
Net Income	2,053.1
Other comprehensive income (loss), net of tax	(153.3)			(153.3)	(153.3)
Dividends, Cash			(1,093.3)		(1,093.3)
Exercise of stock options, shares								1
Exercise of stock options		0.1			0.1
Vesting of issued restricted Class A common stock, shares								239
Vesting of issued restricted Class A common stock		(21.7)			(21.7)
Stock Issued During Period, Shares, Issued for Services								19
Stock Issued During Period, Value, Issued for Services		4			4
Stock Issued During Period, Shares, Employee Stock Purchase Plans								19
Stock Issued During Period, Value, Employee Stock Purchase Plan		3.8			3.8
Stock-based compensation		58.8			58.8
Balance (in shares) at Sep. 30, 2022							358,877	358,877	3	3	4,584
Balance at Sep. 30, 2022	28,250.8	22,238.9	6,111.7	(99.8)	28,250.8
Balance (in shares) at Jun. 30, 2022								358,677		3	4,584
Balance at Jun. 30, 2022		22,235.9	5,797.5	(31.7)	28,001.7
Less: net (income) loss attributable to non-controlling interests	0
Net Income Attributable to CME Group	679.6		679.6		679.6
Net Income	679.6
Other comprehensive income (loss), net of tax	(68.1)			(68.1)	(68.1)
Dividends, Cash			(365.4)		(365.4)
Vesting of issued restricted Class A common stock, shares								200
Vesting of issued restricted Class A common stock		(16.4)			(16.4)
Stock-based compensation		19.4			19.4
Balance (in shares) at Sep. 30, 2022							358,877	358,877	3	3	4,584
Balance at Sep. 30, 2022	$ 28,250.8	$ 22,238.9	$ 6,111.7	$ (99.8)	$ 28,250.8

Consolidated Statements Of Sh_2

Consolidated Statements Of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Cash dividends on common stock, per share (in dollars per share)	$ 1	$ 0.90	$ 3	$ 2.70

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net Cash Provided by (Used in) Operating Activities	$ 2,074.5	$ 1,734.1
Investment in S&P/Dow Jones Indices LLC	410	0
Net cash proceeds from OSTTRA joint venture transaction	0	43.7
Cash Flows from Operating Activities
Net Income	2,053.1	2,011.7
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	58.8	56.6
Amortization of purchased intangibles	171	179
Depreciation and amortization	101	111.9
Gain on deconsolidation of optimization businesses	0	343.5
Net realized and unrealized (gains) losses on investments	(4.1)	(112)
Deferred income taxes	(22.1)	13.8
Change in:
Accounts receivable	(147.4)	(81.8)
Other current assets	(29.5)	(41)
Other assets	76.7	41.6
Accounts payable	46.2	3.6
Income taxes payable	(167.8)	(88.3)
Other current liabilities	0.4	20
Other liabilities	(60.8)	(26.9)
Other	(1)	(10.6)
Net Cash Provided by (Used in) Operating Activities	2,074.5	1,734.1
Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities	5.1	7.4
Purchases of available-for-sale marketable securities	(3.7)	(6.2)
Purchases of property, net	(65.3)	(99.9)
Investment in S&P/Dow Jones Indices LLC	(410)	0
Investments in privately-held equity investments	1.1	1.5
Purchase of non-controlling interest	0	(52)
Proceeds from sales of investments	10.9	99.3
Net Cash Used in Investing Activities	(464.1)	(9.2)
Cash Flows from Financing Activities
Proceeds from debt, net of issuance costs	741	0
Repayment of debt, including call premium	756.2	0
Cash dividends	(2,270)	(1,862.5)
Change in performance bond and guaranty fund contributions	(17,974.7)	62,409.8
Employee taxes paid on restricted stock vesting	(21.7)	(31.2)
Other	(8.9)	(2.7)
Net Cash (Used in) Provided by Financing Activities	(20,290.5)	60,513.4
Net change in cash, cash equivalents and restricted cash	(18,680.1)	62,238.3
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning balance	160,789.9	88,420.3
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, ending balance	142,109.8	150,658.6
Cash and cash equivalents	2,130.1	1,459.4
Short-term restricted cash	4.6	4.8
Long-term restricted cash	0.2	2.8
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)	139,974.9	149,191.6
Income taxes paid	804	612.5
Interest paid	$ 108.7	$ 109.4

Basis Of Presentation

Basis Of Presentation	9 Months Ended
Basis Of Presentation	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis Of Presentation	Basis of Presentation The consolidated financial statements consist of CME Group Inc. (CME Group) and its subsidiaries (collectively, the company), including Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) and NEX Group Limited (NEX). The clearing house is operated by CME. In January 2021, the company announced that it agreed with IHS Markit (now a part of S&P Global) to combine their post-trade services into a new joint venture, OSTTRA. The joint venture was launched in September 2021. OSTTRA performs trade processing and risk mitigation services. The accompanying interim consolidated financial statements have been prepared by CME Group without audit. Certain notes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. In the opinion of management, the accompanying consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial position of the company at September 30, 2022 and December 31, 2021 and the results of operations and cash flows for the periods indicated. Quarterly results are not necessarily indicative of results for any subsequent period. During the fourth quarter of 2021, the company revised the presentation of the consolidated statements of cash flows to include cash performance bonds and guaranty fund contributions as restricted cash and restricted cash equivalents within the beginning and ending balances of the reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents. Total cash flows from financing activities were revised to include the changes associated with the cash performance bonds and guaranty fund contribution liability. See Note 4. Performance Bonds and Guaranty Fund Contributions for additional information on cash performance bonds and guaranty fund contributions. The prior period amounts have been revised to conform to the current period presentation. The revision in presentation is considered immaterial to the company's overall financial statements and has had no impact on the consolidated balance sheets, consolidated statements of income, consolidated statements of comprehensive income or consolidated statements of equity, including all previously filed financial statements. These cash performance bonds and guaranty fund contributions cannot be used for the company's operations or to satisfy any operational liabilities. The following table presents the effects of the changes on the presentation of these cash flows to the previously reported consolidated statements of cash flows of September 30, 2021: 2021 (in millions) As Previously Reported Adjustments Revised Net cash provided by (used in) financing activities $ (1,896.4) 62,409.8 $ 60,513.4 Net change in cash, cash equivalents, restricted cash and restricted cash equivalents (171.5) 62,409.8 62,238.3 The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in CME Group’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (SEC) on February 25, 2022.

Accounting Policies

Accounting Policies	9 Months Ended
Accounting Policies	Sep. 30, 2022
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy	Accounting Policies Newly Adopted Accounting Policies. The company adopted the following accounting policies during 2022: In August 2020, FASB issued an accounting update that simplifies the accounting for convertible instruments and amends certain guidance on the computation of EPS for convertible instruments. This guidance reduces the number of accounting models used for the allocation of proceeds attributable to the issuance of a convertible instrument, thereby eliminating the beneficial conversion feature model. It is also noted that this guidance revises and eliminates certain criteria for achieving equity classification on the balance sheet. This accounting update requires entities to provide expanded disclosures about the terms and features of convertible instruments, including information about events, conditions and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The company adopted this guidance on January 1, 2022. Adoption of this guidance did not have an impact on the consolidated financial statements.

Revenue Recognition (Notes)

Revenue Recognition (Notes)	9 Months Ended
Revenue Recognition (Notes)	Sep. 30, 2022
Revenue Recognition [Abstract]
Revenue Recognition, Deferred Revenue [Policy Text Block]	Revenue Recognition The company generates revenue from customers from the following sources: Clearing and transaction fees. Clearing and transaction fees include electronic trading fees and brokerage commissions, surcharges for privately-negotiated transactions, portfolio reconciliation and compression services, risk mitigation and other volume-related charges for trade contracts. Clearing and transaction fees are assessed upfront at the time of trade execution. As such, the company recognizes the majority of the fee revenue upon successful execution of the trade. The minimal remaining portion of the fee revenue related to settlement activities performed after trade execution is recognized over the short-term period that the contract is outstanding, based on management’s estimates of the average contract lifecycle. These estimates are based on various assumptions to approximate the amount of fee revenue to be attributed to services performed through contract settlement, expiration, or termination. For cleared trades, these assumptions include the average number of days that a contract remains in open interest, contract turnover, average revenue per day, and revenue remaining in open interest at the end of each period. The nature of contracts gives rise to several types of variable consideration, including volume-based pricing tiers, customer incentives associated with market maker programs and other fee discounts. The company includes fee discounts and incentives in the estimated transaction price when there is a basis to reasonably estimate the amount of the fee reduction. These estimates are based on historical experience, anticipated performance, and best judgment at the time. Because of the company's certainty in estimating these amounts, they are included in the transaction price of contracts. Market data and information services. Market data and information services represent revenue from the dissemination of market data to subscribers, distributors, and other third-party licensees of market data. Pricing for market data is primarily based on the number of reportable devices used as well as the number of subscribers enrolled under the arrangement. Fees for these services are generally billed monthly. Market data services are satisfied over time and revenue is recognized on a monthly basis as the customers receive and consume the benefit of the market data services. However, the company also maintains certain annual license arrangements with one-time upfront fees. The fees for annual licenses are initially recorded as a contract liability and recognized as revenue monthly over the term of the annual period. Other. Other revenues include certain access and communication fees, fees for collateral management, equity membership subscription fees, and fees for trade order routing through agreements from various strategic relationships. Access and communication fees are charged to customers that utilize various telecommunications networks and communications services. Fees for these services are generally billed monthly and the associated fee revenue is recognized as billed. Collateral management fees are charged to clearing firms that have collateral on deposit with the clearing house to meet their minimum performance bond and guaranty fund obligations on the exchange. These fees are calculated based on daily collateral balances and are billed monthly. This fee revenue is recognized monthly as billed as the customers receive and consume the benefits of the services. The company also has an equity membership program which provides equity members the option to substitute a monthly subscription fee for their existing requirement to hold CME Group Class A common stock. Choosing to pay this fee in lieu of holding Class A shares is entirely voluntary and the client's choice. Fee revenue under this program is earned monthly as billed over the contractual term. Pricing for strategic relationships may be driven by customer levels and activity. There are fee arrangements which provide for monthly as well as quarterly payments in arrears. Revenue is recognized monthly for strategic relationship arrangements as the customers receive and consume the benefits of the services. The following table represents a disaggregation of revenue from contracts with customers by product line for the quarters and nine months ended September 30, 2022 and 2021: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Interest rates $ 317.8 $ 251.0 $ 1,017.3 $ 816.2 Equity indexes 249.7 181.1 764.7 551.9 Foreign exchange 50.8 39.8 140.8 119.3 Agricultural commodities 104.4 96.3 344.7 354.8 Energy 134.0 157.1 449.4 456.2 Metals 48.4 45.0 148.0 154.8 BrokerTec fixed income 40.7 40.7 127.1 129.0 EBS foreign exchange 36.4 38.8 118.6 125.5 Optimization — 14.0 — 59.9 Interest rate swap 16.4 15.1 50.7 48.2 Total clearing and transaction fees 998.6 878.9 3,161.3 2,815.8 Market data and information services 154.3 145.4 457.7 434.8 Other 74.9 85.6 192.6 291.8 Total revenues $ 1,227.8 $ 1,109.9 $ 3,811.6 $ 3,542.4 Timing of Revenue Recognition Services transferred at a point in time $ 977.1 $ 852.4 $ 3,084.7 $ 2,733.5 Services transferred over time 245.1 255.3 711.9 798.2 One-time charges and miscellaneous revenues 5.6 2.2 15.0 10.7 Total revenues $ 1,227.8 $ 1,109.9 $ 3,811.6 $ 3,542.4 The timing of revenue recognition, billings and cash collections results in billed accounts receivable, and customer advances and deposits (contract liabilities) on the consolidated balance sheets. Certain fees for transactions, annual licenses, and other revenue arrangements are billed upfront before revenue is recognized, which results in the recognition of contract liabilities. These liabilities are recognized on the consolidated balance sheets on a contract-by-contract basis upon commencement of services under the customer contract. These upfront customer payments are recognized as revenue over time as the obligations under the contracts are satisfied. Changes in the contract liability balances during the nine months ended September 30, 2022 were not materially impacted by any other factors. The balance of contract liabilities was $24.4 million and $15.2 million as of September 30, 2022 and December 31, 2021, respectively.

Performance Bonds and Guaranty

Performance Bonds and Guaranty Fund Contributions (Notes)	9 Months Ended
Performance Bonds and Guaranty Fund Contributions (Notes)	Sep. 30, 2022
Performance Bonds and Guaranty Fund Contributions [Abstract]
Performance Bonds and Guaranty Fund Contributions	Performance Bonds and Guaranty Fund Contributions Performance Bonds and Guaranty Fund Contributions. CME has been designated as a systemically important financial market utility by the Financial Stability Oversight Council and is authorized to maintain cash accounts at the Federal Reserve Bank of Chicago. At September 30, 2022, CME maintained $128.6 billion within the cash account at the Federal Reserve Bank of Chicago. The cash deposit at the Federal Reserve Bank of Chicago is included within performance bonds and guaranty fund contributions on the consolidated balance sheets. Clearing House Contract Settlement. The clearing house marks-to-market open positions for all futures and options contracts twice a day (once a day for CME's cleared-only interest rate swap contracts). Based on values derived from the mark-to-market process, the clearing house requires payments from clearing firms whose positions have lost value and makes payments to clearing firms whose positions have gained value. Under the extremely unlikely scenario of simultaneous default by every clearing firm who has open positions with unrealized losses, the maximum exposure related to positions other than cleared-only interest rate swap contracts would be one half day of changes in fair value of all open positions, before considering the clearing house's ability to access defaulting clearing firms' collateral deposits. For CME's cleared-only interest rate swap contracts, the maximum exposure related to CME's guarantee would be one full day of changes in fair value of all open positions, before considering CME's ability to access defaulting clearing firms' collateral. During the first nine months of 2022, the clearing house transferred an average of approximately $6.2 billion a day through its clearing systems for settlement from clearing firms whose positions had lost value to clearing firms whose positions had gained

Intangible Assets And Goodwill

Intangible Assets And Goodwill	9 Months Ended
Intangible Assets And Goodwill	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets And Goodwill	Intangible Assets and Goodwill Intangible assets consisted of the following at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 (in millions) Assigned Value Accumulated Net Book Assigned Value Accumulated Deconsolidation (2) Net Book Amortizable Intangible Assets: Clearing firm, market data and other customer relationships $ 4,656.0 $ (1,849.1) $ 2,806.9 $ 5,818.2 $ (1,847.7) $ (950.0) $ 3,020.5 Technology-related intellectual property 62.5 (53.9) 8.6 175.3 (76.3) (84.6) 14.4 Other 66.0 (29.3) 36.7 105.7 (35.5) (23.1) 47.1 Total amortizable intangible assets $ 4,784.5 $ (1,932.3) $ 2,852.2 $ 6,099.2 $ (1,959.5) $ (1,057.7) $ 3,082.0 Indefinite-Lived Intangible Assets: Trade names 450.0 450.0 Total intangible assets – other, net $ 3,302.2 $ 3,532.0 Trading products (1) $ 17,175.3 $ 17,175.3 (1) Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits. (2) The activity from deconsolidation includes intangible assets as part of the contribution of the net assets of the optimization business to OSTTRA. Total amortization expense for intangible assets was $55.5 million and $59.0 million for the quarters ended September 30, 2022 and 2021, respectively. Total amortization expense for intangible assets was $171.0 million and $179.0 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, the future estimated amortization expense related to amortizable intangible assets is expected to be as follows: (in millions) Amortization Expense Remainder of 2022 $ 57.2 2023 225.5 2024 218.9 2025 218.9 2026 218.9 2027 217.7 Thereafter 1,695.1 Goodwill activity consisted of the following for the periods ended September 30, 2022 and December 31, 2021 : (in millions) Balance at December 31, 2021 Deconsolidation (1) Other Activity (2) Balance at September 30, 2022 CBOT Holdings $ 5,066.4 $ — $ — $ 5,066.4 NYMEX Holdings 2,462.2 — — 2,462.2 NEX 2,959.0 — (80.7) 2,878.3 Other 40.4 — — 40.4 Total Goodwill $ 10,528.0 $ — $ (80.7) $ 10,447.3 (in millions) Balance at December 31, 2020 Deconsolidation (1) Other Activity (2) Balance at December 31, 2021 CBOT Holdings $ 5,066.4 $ — $ — $ 5,066.4 NYMEX Holdings 2,462.2 — — 2,462.2 NEX 3,229.8 (246.2) (24.6) 2,959.0 Other 40.4 — — 40.4 Total Goodwill $ 10,798.8 $ (246.2) $ (24.6) $ 10,528.0 __________ (1) The activity from deconsolidation includes goodwill as part of the contribution of the net assets of the optimization business to OSTTRA. (2) Other activity includes currency translation adjustments.

Investments, Equity Method and

Investments, Equity Method and Joint Ventures	9 Months Ended
Investments, Equity Method and Joint Ventures	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
Investment	Long-Term InvestmentsIn June 2022, the company invested $410.0 million in S&P/Dow Jones Indices LLC (S&P/DJI), which S&P/DJI used as part of the consideration for its acquisition of the IHS Markit index business. Following the additional contribution, the company's ownership interest remained at 27%. At September 30, 2022, the company's investment in S&P/DJI was $1.4 billion.

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt Short-term debt consisted of the following at September 30, 2022 and December 31, 2021: (in millions) September 30, 2022 December 31, 2021 $750.0 million fixed rate notes due September 2022, stated rate of 3.00% (1) $ — $ 749.4 €15.0 million fixed rate notes due May 2023, stated rate of 4.30% 14.5 — Total short-term debt $ 14.5 $ 749.4 (1) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.32%. Long-term debt consisted of the following at September 30, 2022 and December 31, 2021: (in millions) September 30, 2022 December 31, 2021 €15.0 million fixed rate notes due May 2023, stated rate of 4.30% $ — $ 16.8 $750.0 million fixed rate notes due March 2025, stated rate of 3.00% (1) 748.2 747.7 $500.0 million fixed rate notes due June 2028, stated rate of 3.75% 497.6 497.2 $750.0 million fixed rate notes due March 2032, stated rate of 2.65% 741.5 — $750.0 million fixed rate notes due September 2043, stated rate of 5.30% (2) 743.6 743.4 $700.0 million fixed rate notes due June 2048, stated rate of 4.15% 690.9 690.6 Total long-term debt $ 3,421.8 $ 2,695.7 (1) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.11%. (2) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 4.73%. Debt maturities, at par value (in U.S. dollar equivalent), were as follows at September 30, 2022: (in millions) Par Value 2023 $ 14.6 2024 — 2025 750.0 2026 — 2027 — Thereafter 2,700.0

Contingencies

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2022
Loss Contingency [Abstract]
Contingencies	Contingencies Legal and Regulatory Matters. In the normal course of business, the company discusses matters with its regulators raised during regulatory examinations or otherwise subject to their inquiry and oversight. These matters could result in censures, fines, penalties or other sanctions. Management believes the outcome of any resulting actions will not have a material impact on its consolidated financial position or results of operations. However, the company is unable to predict the outcome or the timing of the ultimate resolution of these matters, or the potential fines, penalties or injunctive or other equitable relief, if any, that may result from these matters. A putative class action complaint was filed January 15, 2014 in the Circuit Court of Cook County, Chancery Division, against CME Group Inc. and the Board of Trade of the City of Chicago, Inc. The plaintiffs, certain Class B shareholders of CME Group and Class B members of CBOT, allege breach of contract and breach of the implied covenant of good faith and fair dealing for violations of their core rights granted in the defendants’ respective Certificates of Incorporation. On December 2, 2021, the court granted the plaintiffs’ motion for certification of a damages-only class. No trial date has been set. Given the uncertainty of factors that may potentially affect the resolution of the matter, at this time the company is unable to estimate the reasonably possible loss or range of reasonably possible losses in the unlikely event it were found to be liable at trial. Based on its investigation to date, the company believes that it has strong factual and legal defenses to the claims. In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities. While the ultimate results of such proceedings against the company cannot be predicted with certainty, the company believes that the resolution of any of these matters on an individual or aggregate basis will not have a material impact on its consolidated financial position or results of operations. No accrual was required for legal and regulatory matters as none were probable and estimable as of September 30, 2022 and December 31, 2021. Intellectual Property Indemnifications . Certain agreements with customers and other third parties related to accessing the CME Group platforms, utilizing market data services and licensing CME SPAN software may contain indemnifications from intellectual property claims that may be made against them as a result of their use of the applicable products and/or services. The potential future claims relating to these indemnifications cannot be estimated and therefore no liability has been recorded.

Leases (Notes)

Leases (Notes)	9 Months Ended
Leases (Notes)	Sep. 30, 2022
Leases [Abstract]
Lessee, Leases [Policy Text Block]	Leases The company has operating leases for corporate offices. The operating leases have remaining lease terms of up to 16 years, some of which include options to extend or renew the leases for up to an additional five years, and some of which include options to early terminate the leases in less than 12 months. Management evaluates whether these options are exercisable at least quarterly in order to determine whether the contract term must be reassessed. For a small number of the leases, primarily the international locations, management's approach is to enter into short-term leases for a lease term of 12 months or less in order to provide for greater flexibility in the local environment. For certain office spaces, the company has entered into arrangements to sublease excess space to third parties, while the original lease contract remains in effect with the landlord. The company also has one finance lease, which is related to the sale of our data center in March 2016. In connection with the sale, the company leased back a portion of the property. The sale leaseback transaction was recognized under the financing method and not as a sale leaseback arrangement. The right-of-use lease asset is recorded within other assets, and the present value of the lease liability is recorded within other liabilities (segregated between short term and long term) on the consolidated balance sheets. The discount rate applied to the lease payments represents the company's incremental borrowing rate. The components of lease costs were as follows: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Operating lease expense: Operating lease cost $ 14.2 $ 15.6 $ 43.1 $ 48.7 Short-term lease cost 0.1 0.2 0.3 0.6 Total operating lease expense included in other expense $ 14.3 $ 15.8 $ 43.4 $ 49.3 Finance lease expense: Interest expense $ 0.7 $ 0.7 $ 2.1 $ 2.3 Depreciation expense 2.2 2.2 6.5 6.5 Total finance lease expense $ 2.9 $ 2.9 $ 8.6 $ 8.8 Sublease revenue included in other revenue $ 2.7 $ 2.8 $ 8.2 $ 7.7 Supplemental cash flow information related to leases was as follows: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Cash outflows for operating leases $ 15.9 $ 17.2 $ 49.1 $ 47.3 Cash outflows for finance leases 4.3 4.2 12.8 12.7 Supplemental balance sheet information related to leases was as follows: Operating leases (in millions) September 30, 2022 December 31, 2021 Operating lease right-of-use assets $ 322.0 $ 345.3 Operating lease liabilities: Other current liabilities $ 49.4 $ 47.3 Other liabilities 386.6 449.4 Total operating lease liabilities $ 436.0 $ 496.7 Weighted average remaining lease term (in months) 123 132 Weighted average discount rate 3.8 % 3.9 % Finance leases (in millions) September 30, 2022 December 31, 2021 Finance lease right-of-use assets $ 73.7 $ 80.2 Finance lease liabilities: Other current liabilities $ 8.1 $ 7.9 Other liabilities 69.9 75.9 Total finance lease liabilities $ 78.0 $ 83.8 Weighted average remaining lease term (in months) 102 111 Weighted average discount rate 3.5 % 3.5 % Future minimum lease payments were as follows as of September 30, 2022 for operating and finance leases: (in millions) Operating Leases Remainder of 2022 $ 16.4 2023 66.0 2024 60.3 2025 57.1 2026 52.5 2027 50.2 Thereafter 240.4 Total lease payments 542.9 Less: imputed interest (106.9) Present value of lease liability $ 436.0 (in millions) Finance Leases Remainder of 2022 $ 4.3 2023 17.2 2024 17.4 2025 17.5 2026 17.6 2027 17.8 Thereafter 58.9 Total lease payments 150.7 Less: imputed interest (72.7) Present value of lease liability $ 78.0

Guarantees

Guarantees	9 Months Ended
Guarantees	Sep. 30, 2022
Guarantees [Abstract]
Guarantees	Guarantees Mutual Offset Agreement. CME and Singapore Exchange Limited (SGX) maintain a mutual offset agreement with a current term through May 2023. This agreement enables market participants to open a futures position on one exchange and liquidate it on the other. The term of the agreement will automatically renew for a one-year period after May 2023 unless either party provides advance notice of their intent to terminate. CME can maintain collateral in the form of irrevocable, standby letters of credit. At September 30, 2022, CME was contingently liable to SGX on letters of credit totaling $330.0 million . CME also maintains a $350.0 million line of credit to meet its obligations under this agreement. Regardless of the collateral, CME guarantees all cleared transactions submitted through SGX and would initiate procedures designed to satisfy these financial obligations in the event of a default, such as the use of performance bonds and guaranty fund contributions of the defaulting clearing firm. Management has assessed the fair value of the company's guarantee liability under this mutual offset agreement by taking the following factors into consideration: the design and operations of the clearing risk management process, the financial safeguard packages in place, historical evidence of default by a clearing member and the estimated probability of potential payouts by the clearing house. Based on the assessment performed, management estimates the guarantee liability to be nominal and therefore has not recorded any liability at September 30, 2022 and December 31, 2021. Family Farmer and Rancher Protection Fund. In 2012, the company established the Family Farmer and Rancher Protection Fund (the Fund). The Fund is designed to provide payments, up to certain maximum levels, to family farmers, ranchers and other agricultural industry participants who use the company's agricultural commodity products and who suffer losses to their segregated account balances due to their CME clearing member becoming insolvent. Under the terms of the Fund, farmers and ranchers are eligible for up to $25,000 per participant. Farming and ranching cooperatives are eligible for up to $100,000 per cooperative. The Fund was established with a maximum of $100.0 million available for distribution to participants. Since its establishment, the Fund has made payments of approximately $2.0 million, which leaves $98.0 million available for future claims. If, at any time, payments due to participants were to exceed the amount remaining in the Fund, payments would be pro-rated. Clearing members and customers must register with the company in advance and provide certain documentation in order to substantiate their eligibility. The company believes that its guarantee liability is nominal and therefore has not recorded any liability at September 30, 2022 and December 31, 2021.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Notes)	9 Months Ended
Accumulated Other Comprehensive Income (Notes)	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss): (in millions) Investment Securities Defined Benefit Plans Derivative Investments Foreign Currency Translation Total Balance at December 31, 2021 $ 1.1 $ (34.8) $ 66.1 $ 21.1 $ 53.5 Other comprehensive income (loss) before reclassifications and income tax benefit (expense) (3.0) (3.7) — (148.1) (154.8) Amounts reclassified from accumulated other comprehensive income (loss) — 0.9 (1.0) — (0.1) Income tax benefit (expense) 0.7 0.7 0.2 — 1.6 Net current period other comprehensive income (loss) (2.3) (2.1) (0.8) (148.1) (153.3) Balance at September 30, 2022 $ (1.2) $ (36.9) $ 65.3 $ (127.0) $ (99.8) (in millions) Investment Securities Defined Benefit Plans Derivative Investments Foreign Currency Translation Total Balance at December 31, 2020 $ 1.6 $ (57.1) $ 67.0 $ 123.4 $ 134.9 Other comprehensive income (loss) before reclassifications and income tax benefit (expense) (0.9) — — (58.6) (59.5) Amounts reclassified from accumulated other comprehensive income (loss) 0.2 3.3 (0.9) (40.3) (37.7) Income tax benefit (expense) 0.2 (0.8) 0.2 — (0.4) Net current period other comprehensive income (loss) (0.5) 2.5 (0.7) (98.9) (97.6) Balance at September 30, 2021 $ 1.1 $ (54.6) $ 66.3 $ 24.5 $ 37.3

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2022
Fair Value by Fair Value Hierarchy Level, Extensible Enumeration [Abstract]
Fair Value Measurements	Fair Value Measurements The company uses a three-level classification hierarchy of fair value measurements for disclosure purposes: • Level 1 inputs, which are considered the most reliable evidence of fair value, consist of quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 inputs consist of observable market data, such as quoted prices for similar assets and liabilities in active markets, or inputs other than quoted prices that are directly observable. • Level 3 inputs consist of unobservable inputs which are derived and cannot be corroborated by market data or other entity-specific inputs. The company's level 1 assets generally include investments in publicly traded mutual funds, equity securities and corporate debt securities with quoted market prices. In general, the company uses quoted prices in active markets for identical assets to determine the fair value of marketable securities. The company's level 2 assets and liabilities generally consist of long-term debt notes. The fair values of the long-term debt notes were based on quoted market prices in an inactive market. The company's level 3 assets and liabilities include certain investments that were adjusted to fair value. Recurring Fair Value Measurements. Financial assets and liabilities recorded at fair value on the consolidated balance sheet as of September 30, 2022 were classified in their entirety based on the lowest level of input that was significant to each asset and liability's fair value measurement. The following table presents financial instruments measured at fair value on a recurring basis: September 30, 2022 (in millions) Level 1 Level 2 Level 3 Total Assets at Fair Value: Marketable securities: Corporate debt securities $ 11.6 $ — $ — $ 11.6 Mutual funds 79.6 — — 79.6 Equity securities 0.1 — — 0.1 Total Marketable Securities 91.3 — — 91.3 Total Assets at Fair Value $ 91.3 $ — $ — $ 91.3 Non-Recurring Fair Valu e Measurements. The company also recognized net unrealized losses on investments of $8.9 million on equity investments without readily determinable fair value. The fair value of these investments was estimated to be $36.1 million at September 30, 2022. The assessment was based on quantitative and qualitative indicators of fair value. The fair value measurement of the investment is considered level 3 and non-recurring. Fair Values of Long-Term Debt Notes. The follo wing presents the estimated fair values of long-term debt notes, which are carried at amortized cost on the consolidated balance sheets. The fair values below are classified as level 2 under the fair value hierarchy and were estimated using quoted market prices in inactive markets. At September 30, 2022, the fair values (in U.S. dollar equivalent) were as follows: (in millions) Fair Value Level €15.0 million fixed rate notes due May 2023 14.7 Level 2 $750.0 million fixed rate notes due March 2025 718.9 Level 2 $500.0 million fixed rate notes due June 2028 471.5 Level 2 $750.0 million fixed rate notes due March 2032 617.7 Level 2 $750.0 million fixed rate notes due September 2043 747.5 Level 2 $700.0 million fixed rate notes due June 2048 618.5 Level 2

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The company uses the two-class method to calculate basic and diluted earnings per common share because its Series G preferred stock are participating securities. Under the two-class method, undistributed earnings are allocated to common stock and participating securities according to their respective rights in undistributed earnings, as if all of the earnings for the period had been distributed. Basic earnings per common share is computed by dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding during the period. Net income attributable to common shareholders is reduced for preferred stock dividends earned during the period. Preferred stock also receives a proportionate allocation of undistributed or overdistributed earnings for the period because Series G preferred stock has a contractual obligation to share in profits and losses of the company. Diluted earnings per share is computed by dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding plus potentially dilutive common shares. Anti-dilutive stock awards were as follows for the periods presented: Quarter Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Stock awards 102 — 107 72 Total 102 — 107 72 The following table presents the earnings per share calculation for the periods presented: Quarter Ended Nine Months Ended 2022 2021 2022 2021 Net Income Attributable to CME Group (in millions) $ 679.6 $ 926.5 $ 2,053.1 $ 2,011.2 Less: preferred stock dividends (4.6) — (13.8) — Less: undistributed earnings allocated to preferred stock (3.9) — (12.1) — Net Income Attributable to Common Shareholders of CME Group $ 671.1 $ 926.5 $ 2,027.2 $ 2,011.2 Weighted Average Number of Common Shares (in thousands) : Basic 358,715 358,363 358,655 358,258 Effect of stock options, restricted stock and performance shares 573 625 551 636 Diluted 359,288 358,988 359,206 358,894 Earnings per Common Share Attributable to Common Shareholders of CME Group: Basic $ 1.87 $ 2.59 $ 5.65 $ 5.61 Diluted 1.87 2.58 5.64 5.60

Subsequent Events (Notes)

Subsequent Events (Notes)	9 Months Ended
Subsequent Events (Notes)	Sep. 30, 2022
Subsequent Event [Line Items]
Subsequent Events [Text Block]	Subsequent EventsThe company has evaluated subsequent events through the date the financial statements were issued. The company has determined that there were no subsequent events that met the requirement for recognition or disclosure in the consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
Revenue Recognition (Tables)	Sep. 30, 2022
Revenue Recognition [Abstract]
Disaggregation of Revenue [Table Text Block]	The following table represents a disaggregation of revenue from contracts with customers by product line for the quarters and nine months ended September 30, 2022 and 2021: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Interest rates $ 317.8 $ 251.0 $ 1,017.3 $ 816.2 Equity indexes 249.7 181.1 764.7 551.9 Foreign exchange 50.8 39.8 140.8 119.3 Agricultural commodities 104.4 96.3 344.7 354.8 Energy 134.0 157.1 449.4 456.2 Metals 48.4 45.0 148.0 154.8 BrokerTec fixed income 40.7 40.7 127.1 129.0 EBS foreign exchange 36.4 38.8 118.6 125.5 Optimization — 14.0 — 59.9 Interest rate swap 16.4 15.1 50.7 48.2 Total clearing and transaction fees 998.6 878.9 3,161.3 2,815.8 Market data and information services 154.3 145.4 457.7 434.8 Other 74.9 85.6 192.6 291.8 Total revenues $ 1,227.8 $ 1,109.9 $ 3,811.6 $ 3,542.4 Timing of Revenue Recognition Services transferred at a point in time $ 977.1 $ 852.4 $ 3,084.7 $ 2,733.5 Services transferred over time 245.1 255.3 711.9 798.2 One-time charges and miscellaneous revenues 5.6 2.2 15.0 10.7 Total revenues $ 1,227.8 $ 1,109.9 $ 3,811.6 $ 3,542.4

Intangible Assets And Goodwill

Intangible Assets And Goodwill (Tables)	9 Months Ended
Intangible Assets And Goodwill (Tables)	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Components of intangible assets	Intangible assets consisted of the following at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 (in millions) Assigned Value Accumulated Net Book Assigned Value Accumulated Deconsolidation (2) Net Book Amortizable Intangible Assets: Clearing firm, market data and other customer relationships $ 4,656.0 $ (1,849.1) $ 2,806.9 $ 5,818.2 $ (1,847.7) $ (950.0) $ 3,020.5 Technology-related intellectual property 62.5 (53.9) 8.6 175.3 (76.3) (84.6) 14.4 Other 66.0 (29.3) 36.7 105.7 (35.5) (23.1) 47.1 Total amortizable intangible assets $ 4,784.5 $ (1,932.3) $ 2,852.2 $ 6,099.2 $ (1,959.5) $ (1,057.7) $ 3,082.0 Indefinite-Lived Intangible Assets: Trade names 450.0 450.0 Total intangible assets – other, net $ 3,302.2 $ 3,532.0 Trading products (1) $ 17,175.3 $ 17,175.3 (1) Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits. (2) The activity from deconsolidation includes intangible assets as part of the contribution of the net assets of the optimization business to OSTTRA.
Future estimated amortization expense	As of September 30, 2022, the future estimated amortization expense related to amortizable intangible assets is expected to be as follows: (in millions) Amortization Expense Remainder of 2022 $ 57.2 2023 225.5 2024 218.9 2025 218.9 2026 218.9 2027 217.7 Thereafter 1,695.1
Schedule of Goodwill	Goodwill activity consisted of the following for the periods ended September 30, 2022 and December 31, 2021 : (in millions) Balance at December 31, 2021 Deconsolidation (1) Other Activity (2) Balance at September 30, 2022 CBOT Holdings $ 5,066.4 $ — $ — $ 5,066.4 NYMEX Holdings 2,462.2 — — 2,462.2 NEX 2,959.0 — (80.7) 2,878.3 Other 40.4 — — 40.4 Total Goodwill $ 10,528.0 $ — $ (80.7) $ 10,447.3 (in millions) Balance at December 31, 2020 Deconsolidation (1) Other Activity (2) Balance at December 31, 2021 CBOT Holdings $ 5,066.4 $ — $ — $ 5,066.4 NYMEX Holdings 2,462.2 — — 2,462.2 NEX 3,229.8 (246.2) (24.6) 2,959.0 Other 40.4 — — 40.4 Total Goodwill $ 10,798.8 $ (246.2) $ (24.6) $ 10,528.0 __________ (1) The activity from deconsolidation includes goodwill as part of the contribution of the net assets of the optimization business to OSTTRA. (2) Other activity includes currency translation adjustments.

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt consisted of the following at September 30, 2022 and December 31, 2021: (in millions) September 30, 2022 December 31, 2021 €15.0 million fixed rate notes due May 2023, stated rate of 4.30% $ — $ 16.8 $750.0 million fixed rate notes due March 2025, stated rate of 3.00% (1) 748.2 747.7 $500.0 million fixed rate notes due June 2028, stated rate of 3.75% 497.6 497.2 $750.0 million fixed rate notes due March 2032, stated rate of 2.65% 741.5 — $750.0 million fixed rate notes due September 2043, stated rate of 5.30% (2) 743.6 743.4 $700.0 million fixed rate notes due June 2048, stated rate of 4.15% 690.9 690.6 Total long-term debt $ 3,421.8 $ 2,695.7 (1) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.11%.
Schedule of Maturities of Long-term Debt [Table Text Block]	ebt maturities, at par value (in U.S. dollar equivalent), were as follows at September 30, 2022: (in millions) Par Value 2023 $ 14.6 2024 — 2025 750.0 2026 — 2027 — Thereafter 2,700.0
Schedule of Short-term Debt	Short-term debt consisted of the following at September 30, 2022 and December 31, 2021: (in millions) September 30, 2022 December 31, 2021 $750.0 million fixed rate notes due September 2022, stated rate of 3.00% (1) $ — $ 749.4 €15.0 million fixed rate notes due May 2023, stated rate of 4.30% 14.5 — Total short-term debt $ 14.5 $ 749.4 (1) The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.32%.

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 30, 2022
Leases [Abstract]
Lease, Cost [Table Text Block]	The components of lease costs were as follows: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Operating lease expense: Operating lease cost $ 14.2 $ 15.6 $ 43.1 $ 48.7 Short-term lease cost 0.1 0.2 0.3 0.6 Total operating lease expense included in other expense $ 14.3 $ 15.8 $ 43.4 $ 49.3 Finance lease expense: Interest expense $ 0.7 $ 0.7 $ 2.1 $ 2.3 Depreciation expense 2.2 2.2 6.5 6.5 Total finance lease expense $ 2.9 $ 2.9 $ 8.6 $ 8.8 Sublease revenue included in other revenue $ 2.7 $ 2.8 $ 8.2 $ 7.7
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	Supplemental cash flow information related to leases was as follows: Quarter Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Cash outflows for operating leases $ 15.9 $ 17.2 $ 49.1 $ 47.3 Cash outflows for finance leases 4.3 4.2 12.8 12.7
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]	Supplemental balance sheet information related to leases was as follows: Operating leases (in millions) September 30, 2022 December 31, 2021 Operating lease right-of-use assets $ 322.0 $ 345.3 Operating lease liabilities: Other current liabilities $ 49.4 $ 47.3 Other liabilities 386.6 449.4 Total operating lease liabilities $ 436.0 $ 496.7 Weighted average remaining lease term (in months) 123 132 Weighted average discount rate 3.8 % 3.9 % Finance leases (in millions) September 30, 2022 December 31, 2021 Finance lease right-of-use assets $ 73.7 $ 80.2 Finance lease liabilities: Other current liabilities $ 8.1 $ 7.9 Other liabilities 69.9 75.9 Total finance lease liabilities $ 78.0 $ 83.8 Weighted average remaining lease term (in months) 102 111 Weighted average discount rate 3.5 % 3.5 %
Finance Lease, Liability, Fiscal Year Maturity	(in millions) Finance Leases Remainder of 2022 $ 4.3 2023 17.2 2024 17.4 2025 17.5 2026 17.6 2027 17.8 Thereafter 58.9 Total lease payments 150.7 Less: imputed interest (72.7) Present value of lease liability $ 78.0
Lessee, Operating Lease, Liability, Maturity	Future minimum lease payments were as follows as of September 30, 2022 for operating and finance leases: (in millions) Operating Leases Remainder of 2022 $ 16.4 2023 66.0 2024 60.3 2025 57.1 2026 52.5 2027 50.2 Thereafter 240.4 Total lease payments 542.9 Less: imputed interest (106.9) Present value of lease liability $ 436.0

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
Accumulated Other Comprehensive Income (Tables)	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss): (in millions) Investment Securities Defined Benefit Plans Derivative Investments Foreign Currency Translation Total Balance at December 31, 2021 $ 1.1 $ (34.8) $ 66.1 $ 21.1 $ 53.5 Other comprehensive income (loss) before reclassifications and income tax benefit (expense) (3.0) (3.7) — (148.1) (154.8) Amounts reclassified from accumulated other comprehensive income (loss) — 0.9 (1.0) — (0.1) Income tax benefit (expense) 0.7 0.7 0.2 — 1.6 Net current period other comprehensive income (loss) (2.3) (2.1) (0.8) (148.1) (153.3) Balance at September 30, 2022 $ (1.2) $ (36.9) $ 65.3 $ (127.0) $ (99.8) (in millions) Investment Securities Defined Benefit Plans Derivative Investments Foreign Currency Translation Total Balance at December 31, 2020 $ 1.6 $ (57.1) $ 67.0 $ 123.4 $ 134.9 Other comprehensive income (loss) before reclassifications and income tax benefit (expense) (0.9) — — (58.6) (59.5) Amounts reclassified from accumulated other comprehensive income (loss) 0.2 3.3 (0.9) (40.3) (37.7) Income tax benefit (expense) 0.2 (0.8) 0.2 — (0.4) Net current period other comprehensive income (loss) (0.5) 2.5 (0.7) (98.9) (97.6) Balance at September 30, 2021 $ 1.1 $ (54.6) $ 66.3 $ 24.5 $ 37.3

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Financial instruments measured at fair value on a recurring basis	The following table presents financial instruments measured at fair value on a recurring basis: September 30, 2022 (in millions) Level 1 Level 2 Level 3 Total Assets at Fair Value: Marketable securities: Corporate debt securities $ 11.6 $ — $ — $ 11.6 Mutual funds 79.6 — — 79.6 Equity securities 0.1 — — 0.1 Total Marketable Securities 91.3 — — 91.3 Total Assets at Fair Value $ 91.3 $ — $ — $ 91.3
Fair value of Debt Instruments	At September 30, 2022, the fair values (in U.S. dollar equivalent) were as follows: (in millions) Fair Value Level €15.0 million fixed rate notes due May 2023 14.7 Level 2 $750.0 million fixed rate notes due March 2025 718.9 Level 2 $500.0 million fixed rate notes due June 2028 471.5 Level 2 $750.0 million fixed rate notes due March 2032 617.7 Level 2 $750.0 million fixed rate notes due September 2043 747.5 Level 2 $700.0 million fixed rate notes due June 2048 618.5 Level 2

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Anti-dilutive stock awards were as follows for the periods presented: Quarter Ended Nine Months Ended (in thousands) 2022 2021 2022 2021 Stock awards 102 — 107 72 Total 102 — 107 72
Basic And Diluted Earnings Per Share	The following table presents the earnings per share calculation for the periods presented: Quarter Ended Nine Months Ended 2022 2021 2022 2021 Net Income Attributable to CME Group (in millions) $ 679.6 $ 926.5 $ 2,053.1 $ 2,011.2 Less: preferred stock dividends (4.6) — (13.8) — Less: undistributed earnings allocated to preferred stock (3.9) — (12.1) — Net Income Attributable to Common Shareholders of CME Group $ 671.1 $ 926.5 $ 2,027.2 $ 2,011.2 Weighted Average Number of Common Shares (in thousands) : Basic 358,715 358,363 358,655 358,258 Effect of stock options, restricted stock and performance shares 573 625 551 636 Diluted 359,288 358,988 359,206 358,894 Earnings per Common Share Attributable to Common Shareholders of CME Group: Basic $ 1.87 $ 2.59 $ 5.65 $ 5.61 Diluted 1.87 2.58 5.64 5.60

Basis Of Presentation (Details)

Basis Of Presentation (Details) - USD ($) $ in Millions	9 Months Ended
Basis Of Presentation (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Net Cash Provided by (Used in) Financing Activities	$ (20,290.5)	$ 60,513.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$ (18,680.1)	62,238.3
Previously Reported
Net Cash Provided by (Used in) Financing Activities		(1,896.4)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		(171.5)
Revision of Prior Period, Adjustment
Net Cash Provided by (Used in) Financing Activities		62,409.8
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		62,409.8
restated balance
Net Cash Provided by (Used in) Financing Activities		60,513.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		$ 62,238.3

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Revenue Recognition [Abstract]
Deferred Revenue	$ 24.4	$ 15.2

Revenue Recognition Disaggregat

Revenue Recognition Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total Revenues	$ 1,227.8	$ 1,109.9	$ 3,811.6	$ 3,542.4
Services transferred at a point in time [Member]
Revenues	977.1	852.4	3,084.7	2,733.5
Services transferred over time [Member]
Revenues	245.1	255.3	711.9	798.2
One-time charges and miscellaneous revenues [Member]
Revenues	5.6	2.2	15	10.7
Clearing and transaction fees [Member]
Revenues	998.6	878.9	3,161.3	2,815.8
Total Revenues	998.6	878.9	3,161.3	2,815.8
Clearing and transaction fees [Member] \| Interest rate [Member]
Revenues	317.8	251	1,017.3	816.2
Clearing and transaction fees [Member] \| Equities [Member]
Revenues	249.7	181.1	764.7	551.9
Clearing and transaction fees [Member] \| Foreign Exchange [Member]
Revenues	50.8	39.8	140.8	119.3
Clearing and transaction fees [Member] \| Agricultural commodity [Member]
Revenues	104.4	96.3	344.7	354.8
Clearing and transaction fees [Member] \| Energy [Member]
Revenues	134	157.1	449.4	456.2
Clearing and transaction fees [Member] \| Metal [Member]
Revenues	48.4	45	148	154.8
Clearing and transaction fees [Member] \| Interest Rate Swap [Member]
Revenues	16.4	15.1	50.7	48.2
Clearing and transaction fees [Member] \| BrokerTec Fixed Income
Revenues	40.7	40.7	127.1	129
Clearing and transaction fees [Member] \| EBS Foreign Exchange
Revenues	36.4	38.8	118.6	125.5
Clearing and transaction fees [Member] \| Optimization
Revenues	0	14	0	59.9
Market data and information services
Revenues	154.3	145.4	457.7	434.8
Total Revenues	154.3	145.4	457.7	434.8
Other
Revenues	74.9	85.6	192.6	291.8
Total Revenues	$ 74.9	$ 85.6	$ 192.6	$ 291.8

Performance Bonds and Guarant_2

Performance Bonds and Guaranty Fund Contributions (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Guarantor Obligations [Line Items]
Average Daily Clearing Settlement	$ 6,200
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	142,109.8	$ 160,789.9	$ 150,658.6	$ 88,420.3
Federal Reserve Bank Advances
Guarantor Obligations [Line Items]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 128,600

Intangible Assets And Goodwil_2

Intangible Assets And Goodwill (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of purchased intangibles	$ 55.5	$ 59	$ 171	$ 179

Intangible Assets And Goodwil_3

Intangible Assets And Goodwill (Components Of Intangible Assets) (Details) - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021
Intangible Assets [Line Items]
Intangible assets—other, net		$ 3,302.2	$ 3,532
Intangible assets—other, net		3,302.2	3,532
Intangible assets—trading products	[1]	17,175.3	17,175.3
Trade Names [Member]
Intangible Assets [Line Items]
Total intangible assets - other, net		450	450
Clearing Firm, Market Data And Other Customer Relationships [Member]
Intangible Assets [Line Items]
Assigned Value		4,656	5,818.2
Accumulated amortization		(1,849.1)	(1,847.7)
Intangible assets—other, net		2,806.9	3,020.5
Disposal Group, Including Discontinued Operation, Intangible Assets			(950)
Technology-Related Intellectual Property [Member]
Intangible Assets [Line Items]
Assigned Value		62.5	175.3
Accumulated amortization		(53.9)	(76.3)
Intangible assets—other, net		8.6	14.4
Disposal Group, Including Discontinued Operation, Intangible Assets			(84.6)
Other [Member]
Intangible Assets [Line Items]
Assigned Value		66	105.7
Accumulated amortization		(29.3)	(35.5)
Intangible assets—other, net		36.7	47.1
Disposal Group, Including Discontinued Operation, Intangible Assets			(23.1)
Total Amortizable Intangible Assets [Member]
Intangible Assets [Line Items]
Assigned Value		4,784.5	6,099.2
Accumulated amortization		(1,932.3)	(1,959.5)
Intangible assets—other, net		$ 2,852.2	3,082
Disposal Group, Including Discontinued Operation, Intangible Assets			$ (1,057.7)

[1]Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits. (2) The activity from deconsolidation includes intangible assets as part of the contribution of the net assets of the optimization business to OSTTRA.

Intangible Assets And Goodwil_4

Intangible Assets And Goodwill (Future Estimated Amortization Expense) (Details) $ in Millions	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 57.2
2023	225.5
2024	218.9
2025	218.9
2026	218.9
2027	217.7
Thereafter	$ 1,695.1

Intangible Assets And Goodwil_5

Intangible Assets And Goodwill (Components of Goodwill) (Details) - USD ($) $ in Millions	6 Months Ended	9 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Line Items]
Goodwill		$ 10,447.3	$ 10,528
CBOT
Goodwill [Line Items]
Goodwill		5,066.4	5,066.4	$ 5,066.4
Goodwill, Other Increase (Decrease)	$ 0	0
Disposal Group, Including Discontinued Operation, Goodwill		0	0
NYMEX
Goodwill [Line Items]
Goodwill		2,462.2	2,462.2	2,462.2
Goodwill, Other Increase (Decrease)	0	0
Disposal Group, Including Discontinued Operation, Goodwill		0	0
NEX
Goodwill [Line Items]
Goodwill		2,878.3	2,959	3,229.8
Goodwill, Other Increase (Decrease)	(24.6)	(80.7)
Disposal Group, Including Discontinued Operation, Goodwill		0	(246.2)
Other CME Segments
Goodwill [Line Items]
Goodwill		40.4	40.4	40.4
Goodwill, Other Increase (Decrease)	0	0
Disposal Group, Including Discontinued Operation, Goodwill		0	0
CME Group Inc.
Goodwill [Line Items]
Goodwill		10,447.3	10,528	$ 10,798.8
Goodwill, Other Increase (Decrease)	$ (24.6)	(80.7)
Disposal Group, Including Discontinued Operation, Goodwill		$ 0	$ (246.2)

Investments, Equity Method an_2

Investments, Equity Method and Joint Ventures (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]
Investment in S&P/Dow Jones Indices LLC	$ (410)	$ 0
Schedule of Equity Method Investments [Line Items]
Investment in S&P/Dow Jones Indices LLC	410	$ 0
S&P/DJI
Equity Method Investments and Joint Ventures [Abstract]
Investment in S&P/Dow Jones Indices LLC	$ (410)
Equity Method Investment, Ownership Percentage	27%
Investments	$ 1,400
Schedule of Equity Method Investments [Line Items]
Investment in S&P/Dow Jones Indices LLC	$ 410
Equity Method Investment, Ownership Percentage	27%
Investments	$ 1,400

Debt (Schedule Of Short-Term An

Debt (Schedule Of Short-Term And Long-Term Debt) (Details) € in Millions, $ in Millions	1 Months Ended			9 Months Ended
	Mar. 31, 2015	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Long-term debt				$ 3,421.8		$ 2,695.7
Forward starting interest rate swap agreement fixed rate	3.11%	4.73%	3.32%
Short-term Debt				14.5		749.4
$750.0 million Fixed Rate Notes Due September 2022, stated rate of 3.00% [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 750
Debt Instrument, Maturity Date				Sep. 15, 2022
Debt Instrument, Interest Rate, Stated Percentage				3%	3%
Short-term Debt				$ 0		749.4
€15.0 million fixed rate notes due May 2023 [Member]
Debt Instrument [Line Items]
Long-term debt				$ 0		16.8
Debt Instrument, Face Amount \| €					€ 15
Debt Instrument, Maturity Date				May 01, 2023
Debt Instrument, Interest Rate, Stated Percentage				4.30%	4.30%
$750.0 Million Fixed Rate Notes Due March 2025, stated rate of 3.00% [Member]
Debt Instrument [Line Items]
Long-term debt				$ 748.2		747.7
Debt Instrument, Face Amount				$ 750
Debt Instrument, Maturity Date				Mar. 15, 2025
Debt Instrument, Interest Rate, Stated Percentage				3%	3%
$500.0 Million Fixed Rate Notes Due June 2028, stated rate of 3.75% [Member] [Domain]
Debt Instrument [Line Items]
Long-term debt				$ 497.6		497.2
Debt Instrument, Face Amount				$ 500
Debt Instrument, Maturity Date				Jun. 15, 2028
Debt Instrument, Interest Rate, Stated Percentage				3.75%	3.75%
$750.0 million Fixed Rate Notes Due September 2043, stated rate of 5.30% [Member]
Debt Instrument [Line Items]
Long-term debt				$ 743.6		743.4
Debt Instrument, Face Amount				$ 750
Debt Instrument, Maturity Date				Sep. 15, 2043
Debt Instrument, Interest Rate, Stated Percentage				5.30%	5.30%
$700.0 Million Fixed Rate Notes Due June 2048, stated rate of 4.15% [Member] [Domain] [Domain]
Debt Instrument [Line Items]
Long-term debt				$ 690.9		690.6
Debt Instrument, Face Amount				$ 700
Debt Instrument, Maturity Date				Jun. 15, 2048
Debt Instrument, Interest Rate, Stated Percentage				4.15%	4.15%
$750.0 Million Fixed Rate Notes Due March 2032, Interest Equal To 2.65%
Debt Instrument [Line Items]
Long-term debt				$ 741.5		$ 0
Debt Instrument, Face Amount				$ 750
Debt Instrument, Maturity Date				Mar. 15, 2032
Debt Instrument, Interest Rate, Stated Percentage				2.65%	2.65%

Debt (Schedule Of Maturities Of

Debt (Schedule Of Maturities Of Long-Term Debt) (Details) $ in Millions	Sep. 30, 2022 USD ($)
Debt Disclosure [Abstract]
2022	$ 14.6
2023	0
2024	750
2025	0
2026	0
Thereafter	$ 2,700

Leases (Details)

Leases (Details)	Sep. 30, 2022
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	16
Lessee, Operating Lease, Renewal Term	5
Lessee, Operating Lease, Option to Terminate	12
Lessee, Operating Lease, Term of Contract	12

Leases Lease Costs (Details)

Leases Lease Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Leases Lease Costs (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating Lease, Cost	$ 14.2	$ 15.6	$ 43.1	$ 48.7
Short-term Lease, Cost	0.1	0.2	0.3	0.6
Operating Lease, Expense	14.3	15.8	43.4	49.3
Finance Lease, Interest Expense	0.7	0.7	2.1	2.3
Finance Lease, Right-of-Use Asset, Amortization	2.2	2.2	6.5	6.5
Finance Lease, Expense	2.9	2.9	8.6	8.8
Sublease Income	$ 2.7	$ 2.8	$ 8.2	$ 7.7

Leases Supplemental Cash Flow I

Leases Supplemental Cash Flow Information-Leases (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating Lease, Payments	$ 15.9	$ 17.2	$ 49.1	$ 47.3
Finance Lease, Principal Payments	$ 4.3	$ 4.2	$ 12.8	$ 12.7

Leases Supplemental Balance She

Leases Supplemental Balance Sheet Information-Leases (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Leases [Abstract]
Operating Lease, Right-of-Use Asset	$ 322	$ 345.3
Operating Lease, Liability, Current	49.4	47.3
Operating Lease, Liability, Noncurrent	386.6	449.4
Operating Lease, Liability	$ 436	$ 496.7
Operating Lease, Weighted Average Remaining Lease Term	123 months	132 months
Operating Lease, Weighted Average Discount Rate, Percent	3.80%	3.90%
Finance Lease, Right-of-Use Asset	$ 73.7	$ 80.2
Finance Lease, Liability, Current	8.1	7.9
Finance Lease, Liability, Noncurrent	69.9	75.9
Finance Lease, Liability	$ 78	$ 83.8
Finance Lease, Weighted Average Remaining Lease Term	102 months	111 months
Finance Lease, Weighted Average Discount Rate, Percent	3.50%	3.50%

Leases Operating Leases Future

Leases Operating Leases Future Minimum Payments (Details) $ in Millions	Sep. 30, 2022 USD ($)
Operating Leases, Future Minimum Payments Due [Line Items]
Remainder of 2022	$ 16.4
2023	66
2024	60.3
2025	57.1
2026	52.5
2027	50.2
Thereafter	240.4
Total Operating Lease Payments	542.9
Operating Lease Payments, Less Imputed Interest	(106.9)
Present Value of Operating Lease Liability	$ 436

Leases Capital Leases, Future M

Leases Capital Leases, Future Minimum Payments Due (Details) $ in Millions	Sep. 30, 2022 USD ($)
Finance Leases, Future Minimum Payments Due [Line Items]
Remainder of 2022	$ 4.3
2023	17.2
2024	17.4
2025	17.5
2026	17.6
2027	17.8
Thereafter	58.9
Total Finance Lease Payments	150.7
Finance Lease Payments, Less Imputed Interest	(72.7)
Present Value of Finance Lease Liability	$ 78

Guarantees (Details)

Guarantees (Details)	9 Months Ended
Guarantees (Details)	Sep. 30, 2022 USD ($) years
Guarantor Obligations [Line Items]
Agreement automatic renewal period (in years) \| years	1
Contingent liability to SGX, amount of irrevocable letters of credit	$ 330,000,000
Line of Credit Facility, Commitment Fee Amount	350,000,000
Family Farmer and Ranchers Protection Fund [Member]
Guarantor Obligations [Line Items]
Payment per participant	25,000
Payment per cooperative	100,000
FutureLosses	100,000,000
Payments under Guarantee	2,000,000
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 98,000,000

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Balance		$ 26,787.4	$ 27,399.3	$ 26,351.5
Other comprehensive income (loss), net of tax	$ (68.1)	(68.7)	(153.3)	(97.6)
Balance	28,250.8	27,282.1	28,250.8	27,282.1
Investment Securities [Member]
Balance			1.1	1.6
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)			(3)	(0.9)
Amounts reclassified from accumulated other comprehensive income (loss)			0	0.2
Income tax benefit (expense)			0.7	0.2
Other comprehensive income (loss), net of tax			(2.3)	(0.5)
Balance	(1.2)	1.1	(1.2)	1.1
Defined Benefit Plans [Member]
Balance			(34.8)	(57.1)
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)			(3.7)	0
Amounts reclassified from accumulated other comprehensive income (loss)			0.9	3.3
Income tax benefit (expense)			0.7	(0.8)
Other comprehensive income (loss), net of tax			(2.1)	2.5
Balance	(36.9)	(54.6)	(36.9)	(54.6)
Derivative Investments [Member]
Balance			66.1	67
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)			0	0
Amounts reclassified from accumulated other comprehensive income (loss)			(1)	(0.9)
Income tax benefit (expense)			0.2	0.2
Other comprehensive income (loss), net of tax			(0.8)	(0.7)
Balance	65.3	66.3	65.3	66.3
Foreign Currency Translation [Member]
Balance			21.1	123.4
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)			(148.1)	(58.6)
Amounts reclassified from accumulated other comprehensive income (loss)			0	(40.3)
Income tax benefit (expense)			0	0
Other comprehensive income (loss), net of tax			(148.1)	(98.9)
Balance	(127)	24.5	(127)	24.5
Accumulated Other Comprehensive Income (Loss) [Member]
Balance			53.5	134.9
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)			(154.8)	(59.5)
Amounts reclassified from accumulated other comprehensive income (loss)			(0.1)	(37.7)
Income tax benefit (expense)			1.6	(0.4)
Other comprehensive income (loss), net of tax			(153.3)	(97.6)
Balance	$ (99.8)	$ 37.3	$ (99.8)	$ 37.3

Fair Value Measurements (Narrat

Fair Value Measurements (Narrative) (Details) $ in Millions	9 Months Ended
Fair Value Measurements (Narrative) (Details) $ in Millions	Sep. 30, 2022 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Unrealized Loss on Investments	$ 8.9
Investments, Fair Value Disclosure	$ 36.1

Fair Value Measurements (Financ

Fair Value Measurements (Financial Instruments Measured At Fair Value On A Recurring Basis) (Details) - Fair Value, Recurring [Member] $ in Millions	Sep. 30, 2022 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	$ 91.3
Total Assets at Fair Value	91.3
Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	11.6
Mutual Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading Securities at Fair Value	79.6
Equity Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0.1
Fair Value, Inputs, Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	91.3
Total Assets at Fair Value	91.3
Fair Value, Inputs, Level 1 [Member] \| Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	11.6
Fair Value, Inputs, Level 1 [Member] \| Mutual Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading Securities at Fair Value	79.6
Fair Value, Inputs, Level 1 [Member] \| Equity Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0.1
Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0
Total Assets at Fair Value	0
Fair Value, Inputs, Level 2 [Member] \| Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0
Fair Value, Inputs, Level 2 [Member] \| Mutual Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading Securities at Fair Value	0
Fair Value, Inputs, Level 2 [Member] \| Equity Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0
Total Assets at Fair Value	0
Fair Value, Inputs, Level 3 [Member] \| Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	0
Fair Value, Inputs, Level 3 [Member] \| Mutual Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading Securities at Fair Value	0
Fair Value, Inputs, Level 3 [Member] \| Equity Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable Securities	$ 0

Fair Value Measurements (Estima

Fair Value Measurements (Estimated Fair Values of Long-Term Debt) (Details) - 9 months ended Sep. 30, 2022 € in Millions, $ in Millions	USD ($)	EUR (€)
$750.0 million Fixed Rate Notes Due September 2022, stated rate of 3.00% [Member]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Sep. 15, 2022
€15.0 million fixed rate notes due May 2023 [Member]
Debt Instrument, Face Amount \| €		€ 15
Debt Instrument, Maturity Date	May 01, 2023
$750.0 Million Fixed Rate Notes Due March 2025, stated rate of 3.00% [Member]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Mar. 15, 2025
$500.0 Million Fixed Rate Notes Due June 2028, stated rate of 3.75% [Member] [Domain]
Debt Instrument, Face Amount	$ 500
Debt Instrument, Maturity Date	Jun. 15, 2028
$750.0 million Fixed Rate Notes Due September 2043, stated rate of 5.30% [Member]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Sep. 15, 2043
$700.0 Million Fixed Rate Notes Due June 2048, stated rate of 4.15% [Member] [Domain] [Domain]
Debt Instrument, Face Amount	$ 700
Debt Instrument, Maturity Date	Jun. 15, 2048
$750.0 Million Fixed Rate Notes Due March 2032, Interest Equal To 2.65%
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Mar. 15, 2032
Fair Value, Inputs, Level 2 [Member] \| $750.0 million Fixed Rate Notes Due September 2022, stated rate of 3.00% [Member]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Sep. 15, 2022
Fair Value, Inputs, Level 2 [Member] \| €15.0 million fixed rate notes due May 2023 [Member]
Debt Instrument, Fair Value Disclosure	$ 14.7
Debt Instrument, Face Amount	$ 15
Debt Instrument, Maturity Date	May 31, 2023
Fair Value, Inputs, Level 2 [Member] \| $750.0 Million Fixed Rate Notes Due March 2025, stated rate of 3.00% [Member]
Debt Instrument, Fair Value Disclosure	$ 718.9
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Mar. 15, 2025
Fair Value, Inputs, Level 2 [Member] \| $500.0 Million Fixed Rate Notes Due June 2028, stated rate of 3.75% [Member] [Domain]
Debt Instrument, Fair Value Disclosure	$ 471.5
Debt Instrument, Face Amount	$ 500
Debt Instrument, Maturity Date	Jun. 15, 2028
Fair Value, Inputs, Level 2 [Member] \| $750.0 million Fixed Rate Notes Due September 2043, stated rate of 5.30% [Member]
Debt Instrument, Fair Value Disclosure	$ 747.5
Debt Instrument, Face Amount	$ 750
Debt Instrument, Maturity Date	Sep. 15, 2043
Fair Value, Inputs, Level 2 [Member] \| $700.0 Million Fixed Rate Notes Due June 2048, stated rate of 4.15% [Member] [Domain] [Domain]
Debt Instrument, Fair Value Disclosure	$ 618.5
Debt Instrument, Face Amount	$ 700
Debt Instrument, Maturity Date	Jun. 15, 2048
Fair Value, Inputs, Level 2 [Member] \| $750.0 Million Fixed Rate Notes Due March 2032, Interest Equal To 2.65%
Debt Instrument, Fair Value Disclosure	$ 617.7

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	102	0	107	72
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	102	0	107	72

Earnings Per Share (Net Income

Earnings Per Share (Net Income Attributable To CME Group) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Income Attributable to CME Group	$ 679.6	$ 926.5	$ 2,053.1	$ 2,011.2
Dividends, Preferred Stock	(4.6)	0	(13.8)	0
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	(3.9)	0	(12.1)	0
Net Income Attributable to Common Shareholders of CME Group	$ 671.1	$ 926.5	$ 2,027.2	$ 2,011.2
Basic (in shares)	358,715	358,363	358,655	358,258
Effect of stock options, restricted stock and performance shares	573	625	551	636
Diluted (in shares)	359,288	358,988	359,206	358,894
Earnings per common share, basic (in dollars per share)	$ 1.87	$ 2.59	$ 5.65	$ 5.61
Earnings per common share, diluted (in dollars per share)	$ 1.87	$ 2.58	$ 5.64	$ 5.60